Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 15 | 2025 | 218 | 1.640 |
Why?
|
| Palatine Tonsil | 8 | 2010 | 34 | 0.990 |
Why?
|
| Adenoids | 6 | 2010 | 12 | 0.850 |
Why?
|
| Hypoxia | 8 | 2012 | 247 | 0.810 |
Why?
|
| Polysomnography | 9 | 2025 | 146 | 0.710 |
Why?
|
| Sleep Apnea Syndromes | 4 | 2025 | 84 | 0.710 |
Why?
|
| Adenoidectomy | 5 | 2011 | 84 | 0.390 |
Why?
|
| Snoring | 5 | 2017 | 16 | 0.380 |
Why?
|
| Tonsillectomy | 5 | 2011 | 111 | 0.360 |
Why?
|
| Cognition Disorders | 3 | 2012 | 542 | 0.360 |
Why?
|
| Erythropoietin | 1 | 2012 | 105 | 0.360 |
Why?
|
| Leukotriene Antagonists | 1 | 2008 | 15 | 0.300 |
Why?
|
| Vasculitis | 1 | 2007 | 45 | 0.270 |
Why?
|
| Disease Models, Animal | 5 | 2012 | 4419 | 0.250 |
Why?
|
| Posture | 1 | 2007 | 133 | 0.250 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2025 | 128 | 0.220 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 463 | 0.220 |
Why?
|
| Maze Learning | 4 | 2012 | 101 | 0.200 |
Why?
|
| Narcolepsy | 1 | 2022 | 5 | 0.190 |
Why?
|
| NADPH Oxidases | 3 | 2012 | 105 | 0.190 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2022 | 38 | 0.180 |
Why?
|
| Child, Preschool | 15 | 2025 | 14316 | 0.170 |
Why?
|
| Obesity | 3 | 2011 | 2326 | 0.170 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2022 | 185 | 0.170 |
Why?
|
| Child | 19 | 2025 | 25015 | 0.160 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 161 | 0.160 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 234 | 0.150 |
Why?
|
| Gene Regulatory Networks | 3 | 2011 | 359 | 0.150 |
Why?
|
| Hypertrophy | 5 | 2010 | 101 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2012 | 2896 | 0.140 |
Why?
|
| Tick Paralysis | 1 | 2017 | 1 | 0.140 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 478 | 0.140 |
Why?
|
| Tick-Borne Diseases | 1 | 2017 | 16 | 0.140 |
Why?
|
| Male | 25 | 2025 | 61966 | 0.130 |
Why?
|
| Lipid Peroxidation | 3 | 2012 | 89 | 0.130 |
Why?
|
| Severity of Illness Index | 6 | 2017 | 2917 | 0.130 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 80 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2017 | 86 | 0.130 |
Why?
|
| Oximetry | 1 | 2017 | 174 | 0.130 |
Why?
|
| Sleep | 3 | 2022 | 350 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2022 | 673 | 0.120 |
Why?
|
| Epilepsy | 2 | 2017 | 843 | 0.120 |
Why?
|
| Deoxyguanosine | 2 | 2012 | 12 | 0.120 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 2324 | 0.120 |
Why?
|
| Swimming | 2 | 2012 | 28 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2012 | 949 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2009 | 2383 | 0.110 |
Why?
|
| Case-Control Studies | 4 | 2010 | 3295 | 0.110 |
Why?
|
| Cell Culture Techniques | 3 | 2009 | 269 | 0.100 |
Why?
|
| Tonsillitis | 2 | 2010 | 13 | 0.100 |
Why?
|
| Female | 19 | 2025 | 67790 | 0.100 |
Why?
|
| Women | 1 | 2012 | 17 | 0.100 |
Why?
|
| Injections, Intraperitoneal | 1 | 2012 | 66 | 0.100 |
Why?
|
| Malondialdehyde | 1 | 2012 | 49 | 0.090 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 28 | 0.090 |
Why?
|
| Escape Reaction | 1 | 2012 | 22 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2012 | 4495 | 0.090 |
Why?
|
| Humans | 23 | 2025 | 125613 | 0.090 |
Why?
|
| Evoked Potentials | 2 | 2009 | 111 | 0.090 |
Why?
|
| Cell Shape | 1 | 2011 | 68 | 0.090 |
Why?
|
| Actigraphy | 1 | 2011 | 47 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 71 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 443 | 0.080 |
Why?
|
| Adolescent | 6 | 2025 | 19904 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 305 | 0.080 |
Why?
|
| Time Factors | 4 | 2012 | 6020 | 0.080 |
Why?
|
| Bronchiolitis, Viral | 1 | 2009 | 29 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2011 | 1774 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2012 | 428 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 442 | 0.080 |
Why?
|
| SRS-A | 1 | 2008 | 1 | 0.080 |
Why?
|
| Leukotriene D4 | 1 | 2008 | 5 | 0.080 |
Why?
|
| Cytokines | 3 | 2009 | 1313 | 0.080 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2010 | 114 | 0.080 |
Why?
|
| Memory | 1 | 2012 | 347 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 406 | 0.070 |
Why?
|
| Sulfides | 1 | 2008 | 21 | 0.070 |
Why?
|
| Androstadienes | 1 | 2008 | 49 | 0.070 |
Why?
|
| Cyclopropanes | 1 | 2008 | 68 | 0.070 |
Why?
|
| Acetates | 1 | 2008 | 72 | 0.070 |
Why?
|
| RNA Polymerase II | 1 | 2008 | 89 | 0.070 |
Why?
|
| Catechin | 1 | 2008 | 12 | 0.070 |
Why?
|
| Apoptosis | 3 | 2010 | 1795 | 0.070 |
Why?
|
| Hydroxyurea | 1 | 2008 | 84 | 0.070 |
Why?
|
| Interleukins | 1 | 2008 | 119 | 0.070 |
Why?
|
| Quinolines | 1 | 2008 | 111 | 0.070 |
Why?
|
| Hyperemia | 1 | 2007 | 33 | 0.070 |
Why?
|
| Middle Ear Ventilation | 1 | 2007 | 36 | 0.070 |
Why?
|
| CD40 Ligand | 1 | 2007 | 61 | 0.070 |
Why?
|
| Tyrosine | 1 | 2007 | 146 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2012 | 545 | 0.070 |
Why?
|
| Otolaryngology | 1 | 2009 | 114 | 0.070 |
Why?
|
| Attention | 1 | 2009 | 192 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2008 | 263 | 0.070 |
Why?
|
| Otitis Media | 1 | 2007 | 89 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 563 | 0.060 |
Why?
|
| Prefrontal Cortex | 1 | 2008 | 206 | 0.060 |
Why?
|
| Plant Extracts | 1 | 2008 | 131 | 0.060 |
Why?
|
| Hippocampus | 2 | 2008 | 772 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 295 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2008 | 353 | 0.060 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2009 | 355 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 231 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2009 | 1640 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2547 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1599 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2009 | 552 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1596 | 0.060 |
Why?
|
| Arginine | 1 | 2007 | 332 | 0.060 |
Why?
|
| Sleep Wake Disorders | 1 | 2007 | 188 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2007 | 461 | 0.060 |
Why?
|
| Mice | 5 | 2012 | 17528 | 0.050 |
Why?
|
| Infant | 3 | 2009 | 12758 | 0.050 |
Why?
|
| Asthma | 1 | 2011 | 761 | 0.050 |
Why?
|
| Body Weight | 1 | 2007 | 968 | 0.050 |
Why?
|
| Animals | 7 | 2012 | 33094 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2009 | 4878 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2009 | 768 | 0.050 |
Why?
|
| Risk Factors | 4 | 2009 | 10346 | 0.050 |
Why?
|
| Cognition | 1 | 2008 | 781 | 0.050 |
Why?
|
| Neurons | 1 | 2012 | 1908 | 0.050 |
Why?
|
| Age Factors | 1 | 2009 | 2757 | 0.050 |
Why?
|
| Inflammation | 1 | 2009 | 1428 | 0.050 |
Why?
|
| Lung | 1 | 2008 | 1509 | 0.040 |
Why?
|
| Chemokines | 2 | 2011 | 129 | 0.040 |
Why?
|
| Comorbidity | 3 | 2011 | 1521 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 2585 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6162 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2010 | 224 | 0.040 |
Why?
|
| Rats | 3 | 2008 | 3388 | 0.040 |
Why?
|
| Kentucky | 2 | 2007 | 27 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2010 | 754 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2017 | 45 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 780 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 994 | 0.030 |
Why?
|
| Electromyography | 1 | 2017 | 136 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3557 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 1132 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 3182 | 0.030 |
Why?
|
| Recurrence | 2 | 2009 | 1403 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2009 | 948 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 3884 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2009 | 841 | 0.030 |
Why?
|
| NADPH Oxidase 2 | 1 | 2011 | 38 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2856 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2010 | 27 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 29 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 1632 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 34 | 0.020 |
Why?
|
| Wakefulness | 1 | 2011 | 90 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 150 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 59 | 0.020 |
Why?
|
| Phenotype | 2 | 2011 | 4295 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 135 | 0.020 |
Why?
|
| Self Report | 1 | 2012 | 529 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2022 | 16725 | 0.020 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2008 | 2 | 0.020 |
Why?
|
| Fluticasone | 1 | 2008 | 15 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2008 | 23 | 0.020 |
Why?
|
| Cullin Proteins | 1 | 2008 | 13 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 203 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2008 | 37 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2007 | 3645 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 30189 | 0.020 |
Why?
|
| Tea | 1 | 2008 | 18 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1007 | 0.020 |
Why?
|
| Serine | 1 | 2008 | 161 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 417 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 415 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 842 | 0.020 |
Why?
|
| Causality | 1 | 2007 | 89 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2007 | 31 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 2007 | 68 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 498 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2007 | 114 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 559 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 514 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 523 | 0.020 |
Why?
|
| Computational Biology | 1 | 2011 | 837 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 678 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 3016 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 822 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2008 | 419 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 2597 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 2102 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 2558 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2008 | 1011 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2008 | 752 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 3702 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1543 | 0.010 |
Why?
|
| Parents | 1 | 2009 | 1068 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 3130 | 0.010 |
Why?
|
| Quality of Life | 1 | 2011 | 2007 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 1689 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12334 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 19970 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 27263 | 0.010 |
Why?
|